Commerce RI approves incentives for new Amgen biomanufacturing facility

By
-
PREPARING FOR SUCCESS: Amgen Rhode Island senior associates Devon Zayas, left, and Scott Lyons conduct a safety check prior to using a bioreactor at the company’s West Greenwich facility. / PBN PHOTO/
RUPERT WHITELEY
PREPARING FOR SUCCESS: Amgen Rhode Island senior associates Devon Zayas, left, and Scott Lyons conduct a safety check prior to using a bioreactor at the company’s West Greenwich facility. / PBN FILE PHOTO/RUPERT WHITELEY
PROVIDENCE – The R.I. Commerce Corp on Tuesday approved approximately $8.2 million in incentives with the possibility for up to $9.4 million in incentives for Immunex Rhode Island Corp., a subsidiary of Amgen Inc., for the construction of an approximately $165 million “next-generation” biomanufacturing facility in West Greenwich. The plant will be built on the current…

This week only register to receive unlimited access to all content. Ends October 8th.

Register Now

Already a Subscriber?

Login now

- Advertisement -

If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

RELATED ARTICLESMORE FROM AUTHOR

No posts to display